We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Betting on Streamlined Antibacterial Drug Development
FDA Betting on Streamlined Antibacterial Drug Development
July 17, 2013
The FDA is proposing four drug development approaches that it hopes will help streamline and incentivize development of treatments for patients with antibacterial drug-resistant infections.